What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Obesity
- Gene
Aila Rissanen mostly deals with Internal medicine, Endocrinology, Obesity, Body mass index and Weight loss.
Aila Rissanen interconnects Gastroenterology and Liraglutide in the investigation of issues within Internal medicine.
In general Endocrinology, her work in Insulin resistance, Insulin, Adipose tissue and Diabetes mellitus is often linked to Monozygotic twin linking many areas of study.
Her Obesity research is multidisciplinary, relying on both Twin study, Gerontology and Cohort study.
Her Body mass index research includes themes of Physical exercise and Exon.
Her Weight loss research incorporates elements of Weight gain, Placebo, Tolerability and Surgery.
Her most cited work include:
- Hundreds of variants clustered in genomic loci and biological pathways affect human height (1614 citations)
- Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study (1368 citations)
- Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients (938 citations)
What are the main themes of her work throughout her whole career to date?
Her main research concerns Internal medicine, Endocrinology, Obesity, Body mass index and Weight loss.
Aila Rissanen focuses mostly in the field of Internal medicine, narrowing it down to matters related to Type 2 diabetes and, in some cases, Gastroenterology.
Her study in the field of Insulin resistance, Adipose tissue and Cholesterol also crosses realms of Monozygotic twin.
The Obesity study which covers Twin study that intersects with Clinical psychology.
Her work carried out in the field of Body mass index brings together such families of science as Physiology, Cohort study, Cohort and Heritability.
Her research in Weight loss intersects with topics in Weight gain, Tolerability and Randomized controlled trial, Surgery.
She most often published in these fields:
- Internal medicine (70.00%)
- Endocrinology (60.69%)
- Obesity (39.31%)
What were the highlights of her more recent work (between 2015-2021)?
- Internal medicine (70.00%)
- Endocrinology (60.69%)
- Adipose tissue (23.79%)
In recent papers she was focusing on the following fields of study:
Her scientific interests lie mostly in Internal medicine, Endocrinology, Adipose tissue, Insulin resistance and Obesity.
As part of one scientific family, Aila Rissanen deals mainly with the area of Internal medicine, narrowing it down to issues related to the Type 2 diabetes, and often Concordance, Management of obesity and Placebo.
Aila Rissanen specializes in Endocrinology, namely Body mass index.
Her Adipose tissue research incorporates elements of Calorie restriction, Inflammation, Lipid metabolism, Adipokine and Mitochondrion.
Her Insulin resistance study integrates concerns from other disciplines, such as Metabolite, Metabolic syndrome, Mitochondrial DNA and Saturated fatty acid.
Her work in the fields of Obesity, such as Overweight and Mass index, overlaps with other areas such as Trait.
Between 2015 and 2021, her most popular works were:
- 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial (237 citations)
- Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars (115 citations)
- Obesity Is Associated With Low NAD+/SIRT Pathway Expression in Adipose Tissue of BMI-Discordant Monozygotic Twins (76 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Diabetes mellitus
Internal medicine, Endocrinology, Adipose tissue, Insulin resistance and Obesity are her primary areas of study.
Internal medicine is closely attributed to Placebo in her study.
Her Endocrinology research is multidisciplinary, incorporating perspectives in Twin study, Discordant Twin and Young adult.
Her study on Adipogenesis is often connected to Context as part of broader study in Adipose tissue.
Her Insulin resistance research focuses on Saturated fatty acid and how it relates to Saturated fat, Lipolysis, Unsaturated fat, Triglyceride and Unsaturated fatty acid.
In general Obesity study, her work on Overweight often relates to the realm of Environmental variation, thereby connecting several areas of interest.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
